fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net
fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net home contcat us downloads fetalultrasoundsafety.net
fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net
fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net fetalultrasoundsafety.net
Miscellaneous Items
and Musings

One regrettable consequence of this website may be increased anxiety in pregnant women who are having sonograms.  I very much doubt that there are any fetal consequences; the purpose here is to encourage nuts-and-bolts prudence by the ultrasound community.  Sadly, this community will not do much on its own and some gentle prodding by patients/clients is the only way that I can see to improve the situation.  Is it not peculiar that medical users tend to be self-righteously critical of commercial fetal viewing facilities because of safety concerns?

Thermal Indices:
Increase in tissue temperature caused by ultrasound was the earliest mechanism considered for potential biological effects.   “The TI gives a relative indication of the potential for temperature increase at a specific point along the ultrasound beam.” (17).   One related index - TIB - assesses the particular potential for heating adjacent to fetal bones.  Reference 17 elaborates on the difficulties with using the TI and related indices.  Only the MI is required to be displayed in B-mode; for Doppler and color-flow imaging the TI is supposed to be displayed as the overall energy intensity is relatively higher.  TI may be displayed with B-mode.  TI/TIB values are low for B-mode imaging, but relatively higher for color and PW Doppler.  Looking at the video clips helps explain why, with markedly increased flow effects reflecting higher energy inputs.

The conventional wisdom is that one can draw considerable reassurance from the fact that B-mode ultrasound is unlikely to cause significant heating (4).  I find high TI/TIB values to be rather disturbing, but do not take much reassurance from relatively low values in view of considerations surrounding mechanical effects previously outlined.  I seem to recall a radiology text I once owned mentioning that a fatal whole-body dose of ionizing radiation would only raise body temperature by 0.001 C. 

Ionizing radiation comparisons:
Some years ago I spent time as a medical advisor (from Prince Edward Island!) to our then Atomic Energy Control Board, and retain an interest in risk evaluation of ionizing radiation.  The most recent overview publication is the BEIR VII document from the (US) National Research Council (23). It notes the absence of genetic effects demonstrable in humans, including an extensive follow-up of 30,000 children of exposed atomic bomb survivors.  Given findings obtained from laboratory studies, genetic risks are very low and “one would not expect to see an excess of adverse hereditary effects in a sample of about 30,000 children” (page 9).  Approximate genetic risks are projected from experimental data (page 12).  While attention has been shifting to radiation-induced cancers, minimizing gonadal exposure in diagnostic examinations remains important.  Gonadal exposure is given a significant weighting factor in calculation of whole-body equivalent doses when studies are confined to a limited part of the body.  So, with the comparatively puny data base for reassurance for fetal ultrasound follow-up, why do users tend to act as if fetal sonography is known to be harmless? The information deficiency is especially true for higher output equipment following the increase in regulatory limits in 1992.  Do we have a double standard?

Detecting the risk of breast cancer induction from ten years of annual mammography as an increase over “natural” cancer risk by patient follow-up would require cohorts of tens of millions of women (24) and decades of observation.  Risk estimates for mammography are derived from higher dose exposures, with extrapolation to the diagnostic range on a linear no-threshold assumption.  This assumption is conservative and reasonable, but not universally accepted(40).

ALARA in practice:
Easier said than done in terms of downward adjustment of power settings during examinations.  This is especially true when using harmonic imaging; I find that our Toshiba Aplio can only create satisfactory fetal images on harmonics.  With the real-world pressure to get the optimum study in a reasonable time, constant twiddling with the power and gain settings is probably not practical.  Dr. Abramowicz, in response to my question about whether there was downward adjustment of power settings in the observational study of which he was the senior author, replied that “examinations were usually performed with default settings” (4,21,22).

What to do?
My answer: Those who buy equipment for fetal ultrasound should seek out units and probes that will provide satisfactory images on the lowest default MI settings.  A starting point would be to keep MI values below 0.23 to ensure that fetal eye exposure is no more than the regulatory limits following birth.

Not only will this result in minimized exposure, but it will create market pressures to bring intensities down in general.  Additionally, manufacturers should be encouraged to provide an option for automated real-time adjustments within their systems so that intensities will be dropped when the signal path passes through significant amounts of non-attenuating fluid (maternal bladder, amniotic fluid) before reaching the region of interest as identified by the focal zone selected.  This should be a simple exercise for programmers.  I do not want to inject an adversarial element into the experiences of individual patients, but if they politely encourage the user community perhaps some progress can be made about equipment selection.  I have seen no evidence to suggest that any other approach will work.

Who guards the guards?
This ancient question (Quis custodiet ipsos custodes?) applies in surveillance of modern technology.  Evaluation of safety issues in obstetric/fetal ultrasound should be transferred to some organization with no vested interest and not encumbered by the work patterns of government departments.  There should be more representation from younger individuals – at present there are too many of us older folks with baggage.  We also need a lot more research, although where the money for it would come from is uncertain.  Maybe it sounds delusional, but could the Bill and Melinda Gates Foundation spare a few million for this orphan area?

Justification
The ALARA principle, as borrowed from radiation protection, has two pillars: justification and optimization.  So far this site has largely addressed the optimization aspect in fetal ultrasound – minimizing exposure in an examination that is considered necessary.  Some space for examining justification of fetal examinations is required.  Most recently this has been brought up by the use of 3D/4D sonography for entertainment and bonding purposes, especially with independent commercial facilities offering this service - discussed in section 8.    

Prudently applied, 3D ultrasound can actually shorten exposure duration compared to conventional 2D imaging by taking five 3D volumes of the fetus and then using them “offline” to generate images by slicing in desired planes (26). “It took a mean time of 1.1 minutes to obtain the 3D volumes…With the standard 2D technique, the structural surveys were done in a mean time of 13.9 minutes”.

Although screening ultrasound is now entrenched practice, the benefits may not be as dramatic as one might think.  A Cochrane review of nine trials showed earlier detection of multiple pregnancies and reduced rate of induction of labor for post-term pregnancy, but no differences for substantive clinical outcomes such as perinatal mortality.  When a search for fetal abnormalities was part of the examination, there were increased numbers of pregnancy terminations for fetal anomalies (27).  At the time that screening ultrasound was becoming popularized I wrote an article (28) hoping to stimulate discussion and debate, but without success.  I have to admit that increasing patient obesity now renders it harder to make reliable clinical assessments.

Detection of fetal anomalies can be therapeutically important, but screening can also cause anxiety and distress when “soft markers” for chromosomal abnormalities or anatomical findings of questionable significance are detected.  One such situation is to encounter mild fullness of the drainage of the fetal kidneys; despite knowing that this finding is almost certainly within normal limits the examiner may decide that it is medicolegally a good idea to suggest a repeat study later in the pregnancy.  This sort of problem has been elegantly summarized in the title of an article “Antenatal diagnosis of renal tract anomalies: has it increased the sum of human happiness?” (29).   

An encouraging development has been prevention of neural tube defects (spina bifida etc) with folic acid before and around conception.  Will there be further progress along these lines?

A disturbing consequence of the ability to identify fetal gender has been termination of female fetuses in some societies; it has been estimated that up to 10 million female fetuses have been aborted in India in the last 20 years (30).  It would seem that fetal ultrasound has ended more life than it has saved.  I am pro-choice with misgivings, and find this to be an illustration of Bouchier’s Columbus Principle: Any new activity will cause more trouble than you can possibly imagine.

Addendum September 2007:  The dismal state of what clinical users know about acoustic intensities, and onscreen displays of these values, has been nicely documented in an article in the March 2007 issue of the Journal of Ultrasound in Medicine.  This was a survey of users, principally obstetricians and technologists.  Only 3.8% could describe the mechanical index (MI) properly and only 20% were aware that acoustic indices are displayed on the sonographic monitor during examinations (33).  65% of respondents were female.

UPDATE JULY 2008
 
1.  Recently I saw a large ovarian cyst with homogeneous echoes in which intensity-dependant motion of the contents was demonstrated with B-mode, color Doppler and PW Doppler using our conventional probe for abdominal and obstetric ultrasound.  The cyst had extended into the abdomen, permitting evaluation with this probe through about 2.2 cm of overlying skin and tissues.  Flow of about 1.5 cm/sec was generated by PW Doppler.  I had previously sought this effect in superficially located amniotic fluid with echoes without success, but perhaps amniotic fluid characteristics are not as favourable.  Findings could be reproduced with the same probe in skim milk corresponding to videos in section 6 (but not as pretty); flow with PW Doppler was about 1.5 cm/sec.  Note that this was with our standard 3.5 MHz Toshiba Aplio probe for obstetrics. Can someone else, possessing academic credibility, not work with this sort of model with a variety of situations and publish relevant results?
 
2.  A new article has demonstrated the value of a conventional diagnostic ultrasound system with PW Doppler in accelerating clot dissolution with TPA ("clotbuster") in middle cerebral artery stroke  (34).  Acoustic intensity given by the manufacturer was 179 mW/cm2.  The fraction of this that reaches the vessel of interest is probably less than would be calculated from the conventional derating formula, as reference 13 cites a study of cadaver skulls which demonstrated a 65-90 percent energy loss due to ultrasound accumulation in the overlying temporal bone.
 
Several orders of magnitude separate radiation doses used in conventional radiology imaging and those used in therapy.  While comparison with ultrasound should be applied cautiously, as radiation therapy is usually for cancer, the overlap between diagnostic and therapeutic ultrasound levels is somewhat disturbing to me. Knowing that their equipment may well be generating intensities with biological effects sufficient for therapeutic purposes should make even the most complacent users of fetal imaging a little uneasy.  Nonetheless, I have little optimism that there will ever be any pressure from the broad medical user community on manufacturers to reduce intensities.
 
3.  The April 2008 issue of the Journal of Ultrasound in Medicine is largely devoted to safety issues.  The lowest level of information for evaluation of epidemiological studies is a report from a committee of experts;  the highest level is the randomized controlled trial (35).  Unfortunately, randomized controlled studies are short in supply (36), provide some mildly unsettling information, and probably new studies will be difficult or impossible to implement in a world of routine prenatal ultrasound.
 
Unrealistically optimistic risk evaluation of subprime mortgages, resulting in AAA ratings from supposedly independent rating agencies for "asset backed commercial paper", has led to disastrous financial consequences.  Wishful thinking is not a good basis for risk assessment and reduction.  Anyone who thinks that 40 years of experience with fetal ultrasound can permit confident reassuring statements should note that fetal alcohol syndrome was not described in the United States until 1973.  I am disappointed at physicians and sonographers who say they repeatedly looked at their own fetuses with ultrasound, see no adverse effects in their children after birth, and are therefore confident that fetal exposure to diagnostic ultrasound is safe; this reasoning would earn them an F- in a clinical epidemiology course.  Most cigarette smokers do not develop lung cancer.
 
4.  The possibilities for complex interactions of environmental influences in fetal life and delayed non-cancerous effects in much later life are explored in the July 3rd 2008 issue of The New England Journal of Medicine (37).
 
5.  This website has about 1000 page views/ visits per month.  Despite the invitation under "contact", no-one has responded with information rebutting any of the content.  I have also sought responses directly from several expert sources without any substantiated critical replies - actually a couple that were complimentary.  If new information is supplied, or if I am justly taken to task, an apropriate addendum will be added to the website.

UPDATE OCTOBER/NOVEMBER 2009

Reassurance for Mothers: To repeat the point made in the first paragraph of the introduction, and also the first paragraph of the miscellaneous items section: I doubt that there are significant short or long term adverse effects from fetal exposure to ultrasound. There are no proven hazards that I am aware of. I do not lose any sleep over the ultrasound examinations of my grandchildren.

Fetal Ultrasound and Informed Consent: Given that fetal eye exposure is commonly well above the ophthalmic ultrasound guidelines, the question of obtaining informed consent from the mother arises. After communication with a prominent Canadian medical ethicist, I sent a submission to the Canadian Medical Association Journal which was published as an e-letter and is viewable here.

Delays in Pediatric CT Dose Reduction: CT (computed tomography) scans involve large radiation doses by diagnostic imaging standards. This is of particular importance in children, where radiation risks are greater. It is only in the 21st century, however, that dose reduction protocols for the smaller child body have been published and promoted. The American Roentgen Ray Society was gracious enough to give me space on their web site, viewable here, for comparison of issues in pediatric CT and fetal ultrasound. (Typo in the item - my town is Amherst, not Amyherst)

MRI, Gadolinium and NSF (nephrogenic systemic fibrosis): Visualization of abnormalities with magnetic resonance imaging (MRI) can often be improved by intravenous injection of gadolinium-based compounds. For many years this was thought to be innocuous, and was freely used even in patients in kidney failure. More recently the unusual and unpleasant delayed complication of nephrogenic systemic fibrosis (NSF) has been documented, especially in patients with kidney failure. An October 2009 article describes 36 patients from one institution (38). This unexpected and unintended consequence has probably come to attention because it is such a distinctive disorder; had it been a corresponding increase in stroke or heart attacks obscured by a high background frequency would more prudent user attitudes towards gadolinium have developed or would they still be cavalier?  (38)

Progress: Presentation on safety issues in fetal ultrasound are now part of some refresher courses.

AN ALTERNATIVE TO DOPPLER FETAL MONITORING? While my interest as a radiologist is in imaging ultrasound, probably the largest amount of fetal exposure is from continuous-wave Doppler ultrasound for fetal heart monitoring during labor, and also for nonstress testing for assessment of fetal welfare in late pregnancy. In 1984 I wrote “it is hard to believe that modern technology cannot provide satisfactory tracings from audible fetal heart sounds in most patients. Pressure on manufacturers from the physician-consumer would likely produce results.” (28). A beautiful two-page article in The Lancet the same year provided an example of how such tracings can be obtained (39). If this was a reasonable proposal 25 years ago, surely it is far more so now. My memory was recently jolted while listening to a medical technology lecture which included a discussion of the extraordinary capabilities in submarines for detecting and identifying low-frequency propeller sounds from other vessels. Can we not use military technology for real human advantage (swords into plowshares – Isaiah 2:4)? PubMed review shows some progress in this area and also potential applications to fetal welfare assessment by analysis of heart sounds. I would be particularly interested in feedback about this, as it is outside my usual domain.